It works by blocking the shared α subunit of the IL-4 and IL-13 receptors, effectively disrupting the signaling pathways of IL-4 and IL-13 [12], both of which are pivotal in mediating the inflammatory responses associated with AD. Here, IL4 is linked to Alzheimer disease.